Medical conditions send travel insurance quotes soaring

Travel insurance costs can surge after a medical diagnosis, with one 77-year-old Hampshire retiree saying his premium became “astronomical” after heart problems and quadruple bypass surgery.

The practical consequence is blunt: people with pre-existing conditions may be tempted to skip cover entirely, even though emergency treatment abroad can be ruinously expensive, according to the account provided in the report.

Background

Bernie Lawrence, 77, of Fleet, Hampshire, said he was stunned when he saw the price of travel insurance after his health changed. He told the publication he had been active and fit before developing chest pains while out running in 2018. Nine days later, he underwent quadruple bypass surgery. That sequence matters. Insurers price risk from disclosed medical history, and major cardiac surgery is the kind of event that can sharply alter underwriting.

Lawrence, who usually travels with his wife Barbara, 79, is hardly describing a fringe problem. Travel insurers routinely ask about heart disease, cancer history, respiratory illness and other conditions because these are linked to claims risk abroad. The result: older travellers and people with recent illness can face much higher quotes than healthier peers. The basic logic is easy to follow. The financial burden can still be punishing.

Anyone buying cover in the UK is also navigating a regulated market rather than an informal one. The Financial Conduct Authority oversees insurance conduct, and consumers can escalate disputes to the Financial Ombudsman Service. Travel policies are contracts with exclusions, declarations and cancellation terms that matter intensely once a traveller has a known condition. A cheap premium can turn worthless if the medical screening was incomplete.

What this means

This is where the story stops being anecdotal and becomes a consumer health warning. People with heart disease, recent surgery or other serious conditions are more likely to need care while away, and that is exactly why insurers charge more. High premiums feel unfair when health changed suddenly. They do not erase the underlying risk.

Still, consumers should resist the worst conclusion — that because cover is expensive, travelling uninsured is the sensible middle ground. It isn’t. Emergency evacuation, hospital admission, or treatment for a cardiac event overseas can dwarf even a painful insurance premium. And if a traveller fails to declare a condition, the policy may not pay when it matters most. That is the sentence insurers rarely need to say twice.

The broader policy problem is access. A market that prices genuine risk can also leave older or sicker travellers functionally excluded from ordinary holidays. That tension has been visible across health-related consumer markets, from medicines to insurance to elective care, as readers have seen in UK clears Wegovy tablet for private weight loss. But risk-based pricing is not discrimination by itself. It is the business model.

There is also a public-health angle. Travel is not just leisure; for many retirees it is family life, respite and mental wellbeing. When cover becomes unaffordable after illness, the penalty lands twice — first in health, then in social isolation. That changed when medicine improved survival after events such as bypass surgery. More people are well enough to travel after serious disease. The insurance market has not become gentle in response.

High premiums feel unfair when health changed suddenly. They do not erase the underlying risk.

For consumers, the immediate lesson is plain. Declare every relevant condition. Compare specialist providers. Read the medical screening wording, excesses and exclusions before paying. And keep paperwork from consultants and discharge summaries close to hand if an insurer asks for detail. Those steps won’t guarantee an affordable quote, but they reduce the chance of discovering too late that a policy does not match the traveller’s history.

One caution is essential. This account shows how costly cover can become after serious illness, but it does not prove how common these extreme quotes are across the market because no wider pricing data, sample size or comparative methodology was provided.

Peer review is irrelevant here because this is a consumer pricing report, not a clinical study. But evidence standards still matter. A single case can illustrate a problem vividly while telling us very little about prevalence, average premiums, or whether insurers are pricing similarly across firms. Readers should treat Lawrence’s experience as credible testimony, not a market-wide estimate.

The wider pressure on households is already visible in adjacent areas of health policy, from vaccination access in England offers MenB shots to school leavers to patient safety campaigns such as Merope Mills receives CBE for Martha’s Rule campaign. Different systems, same theme: once health needs become more complex, costs and consequences rise fast. Travel insurance is simply the version that shows up before the plane leaves the runway.

What to watch next is not a vote or a bill but the next booking decision facing older travellers this summer. As holiday departures build, consumer advocates, insurers and regulators will face fresh scrutiny over whether people with declared medical conditions can obtain cover that is both valid and realistically affordable under current UK rules.